Additionally, in metastatic disease, NRAS-mutant melanoma has been reported to be more aggressive than NRAS wild-type melanoma, with poorer survival and a higher percentage of patients developing brain metastases [5,6,7]. The gene discussed is NRAS; the disease is metastatic neoplasm.